HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients

Published:2020 Issue:17 Volume:17 Page:2773-2789
ISSN:1449-1907
Container-title:International Journal of Medical Sciences
language:en
Short-container-title:Int. J. Med. Sci.

Author:

Zhu Xudong,Zhang Yixiao,Bai Yang,Gu Xi,Chen Guanglei,Sun Lisha,Wang Yulun,Qiao Xinbo,Ma Qingtian,Zhu Tong,Bu Jiawen,Xue Jinqi,Liu Caigang

Publisher

Ivyspring International Publisher

Subject

General Medicine

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in hematopoietic cell kinase in cancer progression: Mechanisms and inhibitors;Biomedicine & Pharmacotherapy;2024-07

2. Identification and validation of lipid metabolism-related key genes as novel biomarkers in acute myocardial infarction and pan-cancer analysis;Aging;2024-05-23

3. CD24 May Serve as an Immunotherapy Target in Triple-Negative Breast Cancer by Regulating the Expression of PD-L1;Breast Cancer: Targets and Therapy;2023-12

4. Comprehensive analysis of the HCK gene in myeloid neoplasms: Insights into biological functions, prognosis, and response to antineoplastic agents;Hematology, Transfusion and Cell Therapy;2023-12

5. Gains of 20q11.21 in human pluripotent stem cells: Insights from cancer research;Stem Cell Reports;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP